Growing Prevalence of Osteoarthritis to Drive Viscosupplementation Market Forward from 2019 to 2027: TMR

Growing Prevalence of Osteoarthritis to Drive Viscosupplementation Market Forward from 2019 to 2027: TMR

PR Newswire

ALBANY, N.Y., Sept. 2, 2020

ALBANY, N.Y., Sept. 2, 2020 /PRNewswire/ -- Over the forecast period of 2019 to 2027, the global viscosupplementation market will grow at a rate of about 7%, pulling up the market worth from about USD 2.6 billion in the year 2018 to about USD 4.8 billion by the end of the stated period.

Transparency Market Research Logo

Transparency Market Research notes, "Interplay of several growth factors is witnessed, keeping the market buoyant. Some of the notable trends and drivers include increasing prevalence of osteoarthritis, introduction of new drugs, rapidly ageing population, and growing preference for minimally invasive surgeries."

Request for Analysis of COVID-19 Impact on Viscosupplementation Market– https://www.transparencymarketresearch.com/covid19.php

Key Findings of Global Viscosupplementation Market Study:

For a detailed analysis of global viscosupplementation market by product type, application, source, distribution channel and region, visit TOC https://www.transparencymarketresearch.com/report-toc/10232

Key Drivers of Growth in Global Viscosupplementation Market:

Request Brochure of Viscosupplementation Market Report - https://www.transparencymarketresearch.com/brochure.php

Regional Analysis of Global Viscosupplementation Market:

Analyze global viscosupplementation market growth in 30+ countries including US, Canada, Germany, United Kingdom, France, Italy, Russia, Poland, Benelux, Nordic, China, Japan, India, and South Korea. Request a sample of the study https://www.transparencymarketresearch.com/sample.php

Competitive Landscape of Global Viscosupplementation Market:

Transparency Market Research has covered top companies in its report on global viscosupplementation market. These companies include Sanofi, Anika Therapeutics, Inc., Seikagaku Corporation, Zimmer Biomet, Ferring B.V., LG Chem, Chugai Pharmaceutical Co. Ltd, and Bioventus, Inc.  The report also carries information on product portfolio, recent developments, financials, business strategies, and business segments.

Purchase the Viscosupplementation Market Report - https://www.transparencymarketresearch.com/checkout.php

It is quite pertinent to note here that in the vendor landscape of global viscosupplementation market, players that hold a majority share are Zimmer Biomet, Sanofi, Chugai Pharmaceutical Co. Ltd, and Anika Therapeutics Inc. These players are active and aggressive in terms of growth and use a host of measures to achieve the goal. These include increasing research and development activities, entering partnerships and collaborations, merging with or acquiring other companies. These do not come as a surprise as most players are focusing upon new product development and expanding reach to carve off a higher market share.

Browse More Press Release - https://www.transparencymarketresearch.com/press-releases.htm

Global Viscosupplementation Market: Segmentation

Explore Transparency Market Research's award-winning coverage of the global Healthcare Industry:

Osteoarthritis Drugs Market: Rise in R&D expenditure, increased prevalence of osteoarthritis across the globe, increased geriatric population, rise in awareness regarding degenerative bone diseases in developing countries, and rich pipeline of innovative treatment options are some factors that are expected to boost the global osteoarthritis drugs market during the forecast period.

Hip Replacement Implants Market: The global hip replacement implants market is estimated to be driven by rise in geriatric population and augmented demand for hip arthroplasty/replacement surgical procedures. In addition, high incidences of lower extremity conditions like various hip ailments, osteoporosis, and Osteoarthritis (OA) are further likely to bolster the growth of the global hip replacement implants market.

Orthopedic Biomaterials Market: The global orthopedic biomaterials market is expected to grow at a healthy CAGR of ~7% during the forecast period. The market growth can be largely attributed to the ascending demand for orthopedic implants, surge in the number of sports-related injuries, noteworthy advancements in technology, and growth in the number of research and development activities.

Browse Our Latest Reports - https://www.transparencymarketresearch.com/latest.htm

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."

Browse More Upcoming Reports by Transparency Market Research: https://www.transparencymarketresearch.com/upcoming.htm

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Press Release Source: https://www.transparencymarketresearch.com/pressrelease/viscosupplementation-market.htm

Website: https://www.transparencymarketresearch.com/

Logo: https://mma.prnewswire.com/media/1085206/Transparency_Market_Research_Logo.jpg

Voltar noticias em Inglês